Bob Silverman

Bob Silverman is the Vice President of Business Transactions at Formation Bio, where they focus on accelerating drug development and clinical trials. They previously served as Chief Business Officer at both Turbine and C2i Genomics, playing key roles in innovative cancer monitoring and drug discovery platforms. Silverman held various leadership positions at Roche, including Venture Capital Lead and Global Licensing Director, where they specialized in strategic partnering and licensing. They earned a Juris Doctor from Boston University School of Law after completing a Bachelor of Arts in Chemistry at Franklin & Marshall College.